AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2020
Dec 2, 2020
34705_dirs_2020-12-02_53c59e8f-1504-4400-9bb2-cd33308d023c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2020-11-30
Reporting Person: MUKUNDA RAM (Director, Exec. Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-07 | Common Stock | G | 60000 | $0.00 | Disposed | 3364760 | Direct |
| 2020-06-07 | Common Stock | G | 60000 | $0.00 | Disposed | 3304760 | Direct |
| 2020-11-04 | Common Stock | G | 200000 | $0.00 | Disposed | 3104760 | Direct |
| 2020-11-04 | Common Stock | G | 200000 | $0.00 | Disposed | 2904760 | Direct |
| 2020-11-30 | Common Stock | S | 80000 | $2.3378 | Disposed | 2824760 | Direct |
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15